Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations. Brownlee WJ, Wolf C, Hartung HP, Dingermann T, et al. Mult Scler 2022 Aug 24:13524585221116269. doi: 10.1177/13524585221116269.

Read + Share

Amedeo Smart

Independent Medical Education

Brownlee WJ, Wolf C, Hartung HP, Dingermann T, et al. Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations. Mult Scler 2022 Aug 24:13524585221116269. doi: 10.1177/13524585221116269.
PMID: 36000489